Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Interest Coverage Ratio of 36.46 for Q1 2026, down 55.87% sequentially from 23.39 in Q4 2025, and down 562.21% YoY from 7.89 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Interest Coverage Ratio for 17 years, with the latest figure at 36.46 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 562.21% year-over-year to 36.46 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.56 (down 178.49% YoY) and the FY2025 annual result came in at 5.63, up 47.01% from the prior year.
- Interest Coverage Ratio declined to 36.46 in Q1 2026 per CPIX's latest filing, from 23.39 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 7.89 in Q1 2025 and troughed at 39.09 in Q4 2023.
- A 5-year average of 7.78 and a median of 1.19 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio plunged 855.44% in 2022, then jumped 1515.84% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 19.53 in 2022, then slumped by 100.15% to 39.09 in 2023, then surged by 74.8% to 9.85 in 2024, then plunged by 137.41% to 23.39 in 2025, then plunged by 55.87% to 36.46 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 36.46, 23.39, and 0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.16 Mn | 113.29 Mn | - | -4,365.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.45 |
| Mar 31, 2026 | -36.46 |
| Dec 31, 2025 | -23.39 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -1.01 |
| Mar 31, 2025 | 7.89 |
| Dec 31, 2024 | -9.85 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -39.09 |
| Sep 30, 2023 | -0.52 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | -2.52 |
| Dec 31, 2022 | -19.53 |
| Sep 30, 2022 | -1.19 |
| Jun 30, 2022 | -3.46 |
| Mar 31, 2022 | -1.57 |
| Dec 31, 2021 | -156.99 |
| Sep 30, 2021 | -1.11 |